Skip to main content
Veterinary Medicines

CLAVUNOR LC intramammary suspension for lactating cows

Authorised
  • Amoxicillin
  • Clavulanic acid
  • Prednisolone

Product identification

Medicine name:
КЛАВУНОР LC интрамамарна суспензия за лактиращи крави
CLAVUNOR LC intramammary suspension for lactating cows
Active substance:
  • Amoxicillin
  • Clavulanic acid
  • Prednisolone
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Amoxicillin
    200.00
    milligram(s)
    /
    1.00
    Syringe
  • Clavulanic acid
    50.00
    milligram(s)
    /
    1.00
    Syringe
  • Prednisolone
    10.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        7
        day
      • Milk
        60
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CR02
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Asklep-Pharma OOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
Responsible authority:
  • Bulgarian Agency For Food Safety
Authorisation number:
  • 0022-1558
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 7/06/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 7/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."